
Modified-Release Drug Delivery Technology
Marcel Dekker Inc (Publisher)
1st Edition
Published on 7. November 2002
Book
Hardback
1032 pages
978-0-8247-0869-6 (ISBN)
Article exhausted; check for reprint
Description
Describing formulation challenges and their solutions in the design, development, and commercialization of modified-release drugs delivery systems, this book contains eighty papers that review recent developments in design and manufacturing techniques. It includes detailed descriptions of extended release drug products for the oral, nasal, ophthalmic, pulmonary, vaginal, dermal and transdermal pathways. With the exception of the final section addressing regulatory issues, each section covers a particular route for drug delivery and opens with an overview of the anatomical, physiological, and pharmaceutical basics of each route before moving on to cover specific technologies.
More details
Series
Language
English
Place of publication
New York
United States
Publishing group
Taylor & Francis Inc
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 229 mm
Width: 152 mm
Weight
1542 gr
ISBN-13
978-0-8247-0869-6 (9780824708696)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions

Michael Rathbone | Jonathan Hadgraft | Michael S. Roberts
Modified-Release Drug Delivery Technology
Volume 1
Book
05/2008
2nd Edition
CRC Press
€245.12
Shipment within 15-20 days
Persons
Editor
New Zealand Pharmaceutical Industry, Hamilton Lake
University of London, United Kingdom
Content
Oral modified-release delivery systems; TIMERx oral controlled-release drug delivery system; MASRx and COSRx sustained-release technology; Procise - drug delivery systems based on geometric configuration; ringcap technology; Smartrix system - design characteristics and release properties of a novel erosion-controlled oral delivery system; Theriform technology; Accudep technology for oral modified drug release; osmotically controlled tablets; three-phase pharmaceutical form - THREEFORM - with controlled release of amorphous active ingredient for once-daily administration.